e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gene expression profiling in peripheral blood in COPD
P. Ausin, E. Luesink, J. Kehren, P. Lloyd, P. Barnes, S. Kharitonov (London, United Kingdom; Basle, Switzerland; Barcelona, Spain)
Source:
Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Session:
Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Session type:
E-Communication Session
Number:
408
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Ausin, E. Luesink, J. Kehren, P. Lloyd, P. Barnes, S. Kharitonov (London, United Kingdom; Basle, Switzerland; Barcelona, Spain). Gene expression profiling in peripheral blood in COPD. Eur Respir J 2008; 32: Suppl. 52, 408
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Microarray gene expression profiles in lung tissue of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 537s
Year: 2007
Gene expression profiling of induced sputum from COPD patients and healthy smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006
Gene expression patterns in lung emphysema. A gene microarray analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 87s
Year: 2002
Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
MicroRNA profiling in bronchial biopsies identifies altered expression in asthma and high levels of allergen-modulated epithelial microRNAs
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021
microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Peripheral blood gene expression in COPD patients with morning symptoms
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019
Gene expression profiling of lung adenocarcinoma by microarray analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005
Microarray gene expression profiling in a murine model of asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Gene expression and genetic variations of HSP70TLR2 and TLR4 in COPD
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021
Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Chemokine mRNA expression profiling in pulmonary sarcoidosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Changes in gene expression associated with COPD revealed by low density microarray analysis
Source: Eur Respir J 2006; 28: Suppl. 50, 584s
Year: 2006
Transcript profiling of alveolar macrophages reveals a unique molecular finger print compared to CD14
++
and CD14
+
CD16
+
monocytes in blood
Source: Eur Respir J 2006; 28: Suppl. 50, 853s
Year: 2006
Gene expression profiling: can we identify the right target genes?
Source: Eur Respir Rev 2008; 17: 163-167
Year: 2008
Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007
Gene expression profiling identifies neutrophilic and eosinophilic asthma as distinct subtypes
Source: Eur Respir J 2007; 30: Suppl. 51, 526s
Year: 2007
Transcriptome profiling of platelets from patients with severe asthma.
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept